Chargement en cours...
Predictors of immunotherapy benefit in Merkel cell carcinoma
Merkel cell carcinoma is a rare cancer for which immune checkpoint blockade is standard-of-care for recurrent/metastatic disease. However, not all patients benefit from immunotherapy. A greater understanding of molecular mechanisms and predictive biomarkers are unmet needs. We retrospectively analyz...
Enregistré dans:
| Publié dans: | Oncotarget |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Impact Journals LLC
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7720777/ https://ncbi.nlm.nih.gov/pubmed/33315984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27823 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|